(Q70216125)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Pergolide: long-term use in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

1

J E Ahlskog

1 reference

9 October 2019

M D Muenter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 October 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

979-987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Success and problems of long-term levodopa therapy in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Long-term follow-up of early dopa treatment in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Double-blind trial of pergolide for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Treatment of Parkinson's disease with pergolide: a double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Long-term study of pergolide in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Parkinsonism: onset, progression, and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Neurotransmitter receptor alterations in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Receptor basis for dopaminergic supersensitivity in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Dopamine receptor agonists: intrinsic activity vs. state of receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

Altered pharmacokinetics of L-dopa metabolism in rat striatum deprived of dopaminergic innervation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

inferred from DOI database lookup

7 January 2021

based on heuristic

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2964912-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)64912-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3050301%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference